Tirzepatide is a groundbreaking therapeutic agent for individuals struggling type 2 diabetes. As a dual stimulator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide https://laraudhw332091.develop-blog.com/48398942/tirzepatide-a-new-frontier-in-diabetes-treatment